Sabby Management, LLC: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1535610) · Explore on the interactive board
Sabby Management, LLC disclosed 16 US equity positions worth $12.0m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is SPY at 34.2% of the reported book, followed by TOYO CO LTD, FARMMI INC. The top ten holdings are 94.7% of the book, and the portfolio behaves like about 5 equal-weight positions. Versus the prior filing it opened 8 new positions, added to 4, reduced 4 and exited 14. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Sabby Management, LLC own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 8 new, 4 added, 4 reduced, 14 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | SPY STATE STREET SPDR S&P | 34.2% | $4.1m | 5,500 | 101% | added | |
| 2 | TOYO CO LTD | 29.1% | $3.5m | 503,846 | – | new | |
| 3 | FARMMI INC | 7.0% | $840.3k | 3,515,929 | – | new | |
| 4 | CRVO CERVOMED INC | 6.4% | $771.5k | 248,880 | – | new | |
| 5 | TEMPEST THERAPEUTICS INC | 4.7% | $567.5k | 511,286 | 2763% | added | |
| 6 | PARANOVUS ENTERTNMNT TECH LT | 4.7% | $560.5k | 75,440 | – | new | |
| 7 | BIOAFFINITY TECHNOLOGIES | 2.5% | $296.9k | 365,647 | – | new | |
| 8 | SMART POWER CORP | 2.2% | $263.2k | 127,774 | – | new | |
| 9 | BRIACELL THERAPEUTICS CORP | 2.2% | $261.5k | 80,721 | 9% | added | |
| 10 | REVELATION BIOSCIENCES INC | 1.8% | $216.9k | 210,582 | 112% | added | |
| 11 | SNES SENESTECH INC | 1.8% | $211.2k | 141,756 | -35% | reduced | |
| 12 | BRIACELL THERAPEUTICS CORP | 1.4% | $169.4k | 190,383 | -50% | reduced | |
| 13 | SIDU SIDUS SPACE INC | 1.0% | $121.9k | 43,377 | – | new | |
| 14 | INM INMED PHARMACEUTICALS | 0.6% | $69.7k | 44,970 | -80% | reduced | |
| 15 | NUWELLIS INC | 0.4% | $49.9k | 16,372 | – | new | |
| 16 | BRIACELL THERAPEUTICS CORP | 0.1% | $11.5k | 120,802 | -42% | reduced |
What did Sabby Management, LLC sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| ALPHATON CAPITAL CORP | 25.6% | $654.8k |
| BIG TREE CLOUD HLDGS LTD | 13.2% | $337.1k |
| TOKEN CAT LTD | 9.5% | $241.7k |
| POP CULTURE GROUP CO LTD | 7.9% | $201.1k |
| MOLECULIN BIOTECH INC | 6.7% | $171.8k |
| BIODEXA PHARMACEUTICALS PLC | 6.2% | $159.1k |
| RKDA ARCADIA BIOSCIENCES INC | 6.2% | $158.1k |
| TRX TRX GOLD CORP | 5.9% | $150.0k |
| CAN FITE BIOFARMA LTD | 5.2% | $131.9k |
| CHINA SXT PHARMACEUTICALS INC | 5.1% | $131.3k |
| CALIDI BIOTHERAPEUTICS INC | 4.1% | $103.9k |
| BLUEJAY DIAGNOSTICS INC | 2.1% | $52.9k |
| LYRA THERAPEUTICS INC | 2.0% | $51.1k |
| BNB PLUS CORP | 0.3% | $8.7k |
Sector mix
| Sector | Weight |
|---|
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Sabby Management, LLC's portfolio?
Across every quarter Sabby Management, LLC has filed, its median largest position is 32.6% of the book and its median top-ten weight is 87.7%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 14.0 completed holding spells, the median lasted 1.0 quarters; 16.0 positions are still open and their final length is unknown.